Αποτελέσματα Αναζήτησης
Ali Tahri's 20 research works with 110 citations and 2,811 reads, including: Risk factors for inflammatory and non-inflammatory breast cancer in North Africa
Professor of Medicine, Hematology & Oncology, American University of Beirut Medical Center - Cited by 27,931 - Thalassemia - Sickle Cell Disease - Thrombosis - Bleeding - Anemia
عرض ملف Ali Tahri الشخصي على LinkedIn، وهو مجتمع احترافي يضم مليار عضو. Professeur en oncologie Radiotherapie Directeur médical à l’hôpital international IBN NAFIS · الخبرة: Hôpital...
Abstract. Metastatic breast cancer (MBC) is an incurable disease. The goal of treatment is mainly palliative to improve quality of life by the control of disease (in terms of disease free survival [DFS]) as long as possible, and to treat symptoms with fewer side effects. The gene c-erb B2 or neu or HER2 is amplified in 20-25% of breast cancers.
23 Αυγ 2023 · In this case-control study in Egypt, Tunisia, and Morocco, we examined many under-studied potential risk factors for IBC and non-IBC, including time since last birth, breast problems during and outside lactation, breast injury, diabetes, agricultural exposures, and childhood socioeconomic status.
Background: The HER2 gene or c-erb B2 or neu is amplified in 15-25% of breast cancers. This amplification is associated with an aggressive course of disease. The trastuzumab is a monoclonal antibody targeting the extracellular domain of HER2.
1 Ιαν 2013 · Metastatic breast cancer (MBC) is an incurable disease. The goal of treatment is mainly palliative to improve quality of life by the control of disease (in terms of disease free survival [DFS]) as...
